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A B S T R A C T
Background and Objectives: Gastric surgery is a major operation which can cause a related potential
deterioration in the patient’s quality of life (QoL). This retrospective study investigates the factors which can
inﬂuence QoL in patients who underwent curative total or subtotal gastrectomy for cancer.
Methods: One hundred and three patients were treated via gastrectomy between August 1990 and
September 2012: 48 total gastrectomies with Roux-en-Y reconstruction and 55 subtotal resections (among
the latter there were 15 Roux-en-Y and 40 Billroth II reconstructions). All patients were interviewed to
evaluate their QoL using the EORTC QLQ-C30 and QLQ-STO22 questionnaires. Non-parametric tests were
used to analyze the data collected during the interviews considering patient-, tumor- and treatment-related
factors. The analysis was corrected for potential confounding factors, in particular considering new onset
variables (e.g. comorbidity, treatment and age at time of the interview).
Results: QoL correlated negatively with tumor stage and total gastrectomy. In particular, a larger resection
for an advanced cancer seems to cause a worse QoL. Furthermore, total gastrectomy is associated with
several upper-gastrointestinal tract symptoms. Moreover, after distal resection, patients with a Billroth II
reconstruction complain more frequently of dumping syndrome-related symptoms than patients with a
Roux-en-Y reconstruction.
Conclusions: QoL after gastric surgery for cancer is affected by tumor- and treatment-related factors. In order
to improve patients’ QoL, subtotal resection with Roux-en-Y reconstruction should be preferred whenever
oncologically acceptable.
© 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Quality of Life (QoL) is deﬁned by the World Health Organization
(WHO) as individuals’ perception of their position in life in the
cultural context and in the value system in which they live, and in
relation to their goals, expectations, standards and concerns. 1 This is
a broad concept embracing the person’s physical health, psychological
insight, level of independence, social relationships, personal beliefs
and their relationshipwith the environment inwhich all those factors
develop. 1
As a matter of fact, the health-related QoL should include phys-
ical, social and psychological aspects. 2 Several questionnaires are
available to investigate those subjective parameters in oncology. 3–8
Among these, the European Organization for Research and Treatment
of Cancer Life Core-30 (EORTC QLQ-C30) questionnaire has been well
validated. 9,10 We used the EORTC questionnaire because it allows a
complete analysis of the physical, psychological and social aspects of
the individual.
Gastric surgery is a major operation which can cause a related
potential deterioration in the patient’s QoL; therefore, QoL in gastric
cancer surgery is an important topic. 11 In fact, in gastric cancer
management it is a very difﬁcult task to achieve a balance between
oncological radicality and the patient’s wellbeing.
This retrospective study investigated the factors which can in-
ﬂuence QoL, evaluated via EORTC items (QLQ-C30 and the speciﬁc
questionnaire QLQ-STO220 for gastric surgery) for patients who
underwent total or subtotal gastrectomy for cancer with curative
intent.
2. Patients and methods
2.1. Patients
We considered 299 patients with a diagnosis of gastric adenocarci-
noma who underwent potentially curative gastrectomy. At follow up,
carried out between October 2011 and January 2013, 109 patients
(36.4%) were alive: of these, 6 were excluded from the study because
they were not available to complete the questionnaire. Therefore,
103 patients answered all questions of the EORTC QLQ-C30 and
QLQ-STO22.
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2.2. Treatment details
A retrospective analysis of the medical charts was performed consid-
ering in particular the age of patients at time of the surgical operation,
gender, gastrointestinal comorbidities (peptic disease, gallbladder
stones, chronic pancreatitis), general comorbidities (diabetes melli-
tus, renal failure, cardiovascular disease), tumor site and size, duration
and surgical procedures (total versus subtotal gastrectomy, Billroth II
versus Roux-en-Y, manual reinforcement over duodenal stump,
multi-visceral resection), lymph node dissection (D1 vs D2), surgical
radicality (R), histological type (Lauren classiﬁcation, pathological
staging according to the UICC TNM classiﬁcation, 7th edition, 2010),
length of postoperative hospital stay, post-operative complications
and adjuvant therapy. In order to correct the analysis for potential
confounding factors, some other variables collected at the time of
questionnaire administration were considered: time from surgery to
the interview, age, contemporary comorbidities or chemotherapy/
radiotherapy.
Depending on the tumor site, total or subtotal gastrectomy
(TG or SG) was performed considering safe free resection margins.
D1 dissection was performed in 84 patients and D2 dissection in
19 patients.
In all 48 patientswhounderwent TG, reconstructionwasperformed
via Roux-en-Y anastomosis. In the 55 patientswho underwent SG, the
reconstruction was via Billroth II anastomosis in 40 cases (72.7%) and
via Roux-en-Y anastomosis in 15 cases (27.3%), depending on patient
age and surgical risk or on surgeon’s preference. In older patient
or patients with high surgical risk, BII reconstruction was preferred
because it involves only one anastomosis with a signiﬁcantly shorter
operative time.
2.3. Assessment of QoL
The EORTC QLQ-C30 is a cancer-speciﬁc 30-question instrument
for evaluating the postoperative QoL. The questionnaire items
are grouped into ﬁve functional scales (physical, role, cognitive,
emotional, social), three symptom scales (fatigue, pain, nausea and
vomiting), a global health status and QoL scale, and single items
(dyspnea, insomnia, appetite loss, constipation, diarrhea, ﬁnancial
difﬁculties). Of the 30 items, 28 are scored on four-point Likert scales
and the remaining 2 items (29 and 30, for global health status) are
scored on modiﬁed seven-point linear analog scales. 9–11
The EORTC QLQ-STO22 takes into consideration 22 additional
relating to gastric cancer, including ﬁve scales (dysphagia, chest and
abdominal pain, reﬂux, eating restrictions, anxieties) and four single
items (dry mouth, body image, taste problems, hair loss), reﬂecting
disease symptoms, treatment side effects, and emotional issues, with
higher scores indicating worse symptomatic problems. 9–11
2.4. Statistical analysis
In this study we considered as end-points the individual questions of
the EORTC QLQ-C30 and QLQ-STO22, for a total of 52 questions. The
end-pointswere assigned a score between 1 and 4,with the exception
of questions 29 and 30 of the QLQ-C30 module.
When indicated, in order to assess differences between the end-
points and the variables, non-parametric tests were used for the
statistical analysis. All statistical analyses were performed using
SPSS software (version 16.0). A p-value of <0.05 was considered
statistically signiﬁcant.
3. Results
All 103 patients answered the 52 questions. Sample characteristics
are reported in Table 1. The mean time between surgery and
Table 1
Sample characteristics (103 patients)
Variable No. of patients
or mean±SD
Percentagea
Age 64.7±12.7 −
Gender
Male 63 61.2
Female 40 38.8
Previous abdominal surgery (yes) 56 54.4
No gastrointestinal comorbidities 81 78.6
Comordibidities at admission 79 76.7
Tumor site
1/3 Proximal 33 32.0
2/3 Distal 70 68.0
Duration of surgery (min) 210±62.9
Gastrectomy
Total 48 46.6
Subtotal 55 53.4
Lymphadenectomy
D1 84 81.6
D2 19 18.4
Surgical reconstruction
Billroth I 40 38.8
Roux-en-Y 63 61.2
Manual reinforcement on the duodenal stump
Yes 46 44.7
No 57 55.3
Multivisceral resection
Yes 6 5.8
No 97 94.2
Radicality
R(0) 95 92.2
R(1–2) 8 7.8
Tumor size (mm) 37.3±24.4
Lauren type
Diffuse 36 35.0
Intestinal 46 44.7
Undetermined 21 20.4
Grading
G1 6 5.8
G2 44 42.7
G3 53 51.5
Lymph nodes retrieved 21.1±14.5
Positive lymph nodes 2.3±4.1
pT (UICC 2010)
1 35 34.0
2 15 14.6
3 31 30.1
4 22 21.4
pN (UICC 2010)
0 53 51.5
1 19 18.4
2 22 21.4
3 9 8.7
Postoperative hospital stay (days) 15.5±8.6
Postoperative complications
Yes 31 30.1
No 72 69.9
Adjuvant therapy
Yes 42 40.8
No 61 59.2
a Percentages may not add up to 100% due to rounding.
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Table 2
Factors signiﬁcantly associated with questionnaire items
Item/score Factor p-value Item/score Factor p-value
13. Have you lacked appetite?
Surgical procedure (TG/SG) 0.01
1 32/53
2 6/0
3 5/1
4 5/1
Multivisceral resection (Yes/No) 0.01
1 5/80
2 0/6
3 0/6
4 1/5
14. Have you felt nauseated?
Surgical procedure (TG/SG) 0.031
1 37/52
2 6/1
3 1/2
4 3/0
Multivisceral resection (Yes/No) 0.008
1 3/87
2 5/2
3 3/0
4 1/2
Lymphadenectomy (D1/D2) 0.002
1 76/14
2 5/2
3 3/0
4 0/3
17. Have you had diarrhea?
Surgical procedure (TG/SG) 0.007
1 35/52
2 12/2
3 1/1
4 −
Multivisceral resection (Yes/No) 0.007
1 3/84
2 2/12
3 1/1
4 −
pN (N0/N1/N2/N3) 0.001
1 46/16/18/7
2 5/3/4/0
3 0/0/0/2
4 −
22. Did you worry?
Surgical procedure (TG/SG) 0.008
1 25/43
2 15/11
3 7/0
4 1/1
Tumor site (proximal/distal) 0.007
1 17/51
2 10/16
3 6/1
4 0/2
34. Have you had discomfort when eating?
Surgical procedure (TG/SG) 0.003
1 30/49
2 13/5
3 5/0
4 0/1
# Total lymph nodes 0.009
35. Have you had pain in your stomach area?
Surgical procedure (TG/SG) 0.045
1 37/52
2 4/1
3 7/2
4 −
40. Have you had trouble with belching?
Surgical procedure (TG/SG) 0.038
1 28/39
2 11/10
3 3/6
4 6/0
Contemporary chemotherapy (Yes/No) 0.046
1 7/60
2 7/14
3 0/9
4 1/5
Lymphadenectomy (D1/D2) 0.005
1 58/8
2 14/8
3 9/0
4 3/3
questionnaire administration was 81±80.7 months (range 2–300
months). The median age of the patients at the time of questionnaire
administration was 70.9±11.8 years (range 41–99 years). At the time
of the interview 33 patients (32%) had severe general comorbidities
and 15 (14.6%) were undergoing chemotherapy.
Tables 2 and 3 show the statistically signiﬁcant associations
between symptoms and variables, evaluated via EORTC items, for
all 103 patients (Table 2) and for the subset of 55 patients who
underwent SG (Table 3).
QoL is inﬂuenced by several factors, but in particular by disease
stage and related treatment.
TG was associated with a worse QoL, particularly if combined
with extended lymphadenectomy (D2 dissection or number of nodes)
and multi-visceral resection (Table 2): this was reﬂected in EORTC
QLQ-C30 by loss of appetite (question 13), nausea (question 14),
diarrhea (question 17) and anxiety (question 22) and in EORTC QLQ-
STO22 by malabsorption and malnutrition: discomfort during eating
(question 34), epigastric pain (question 35), postprandial belching
(question 40) and worrying about low weight (question 48).
The number and the relative percentage of patientswho gave a high
score to their health status and QoL (score range 5–7) was higher in
the SG group (Fig. 1). Indeed, TG negatively affects QoL and health
status evaluation. Only 37 of 48 patients (77.1%) in the TG group
reported a satisfactory QoL score (5–7), versus 47 of 55 patients
(85.5%) in the SG group; also, only 37 patients (77.1%) in the TG group
reported a health status score of 5–7, versus 45 patients (81.8%) in the
SG group.
The second part of the study focused on the surgical strategy
after SG (Table 3). As to reconstruction, Roux-en-Y does not seem to
be superior to Billroth II in preventing reﬂux symptoms (questions
38 and 39), but it produces statistically better results for symptoms
related to dumping syndrome: need for resting after eating (ques-
tion 10), discomfort duringmeals (question 34) and symptoms related
to abdominal distention (question 37). Furthermore, Roux-en-Y
appears to be related to less limitations in daily activities (question 6).
The number and the relative percentage of patients who gave a high
score to their health status and QoL (score range 5–7) was higher in
the Roux-en-Y group (Fig. 2).
ORIGINAL ARTICLE
S. Rausei et al. / International Journal of Surgery 11S1 (2013) S104–S109 S107
Table 3
Results for the subgroup of 55 patients who underwent subtotal gastrectomy (40 Billroth II [BII] and
15 Roux-en-Y [R-en-Y])
Item/score Surgical reconstruction (BII/R-en-Y) p-value
6. Were you limited in doing either your work or other daily activities? 0.041
1 33/11
2 0/1
3 1/3
4 6/0
10. Did you need rest? 0.093
1 27/8
2 4/3
3 3/4
4 5/0
28. Has your physical condition or medical treatment caused you ﬁnancial difﬁculties? 0.010
1 39/11
2 1/1
3 0/3
4 −
34. Have you had discomfort when eating? 0.070
1 34/15
2 5/0
3 −
4 1/0
37. Did you have a bloated feeling in your abdomen? 0.038
1 30/8
2 5/7
3 4/0
4 1/0
47. Have you been thinking about your illness? 0.092
1 28/6
2 7/5
3 3/3
4 2/1
51. Have you lost any hair? 0.078
1 37/11
2 2/1
3 1/3
4 −
Finally, contemporary variables were signiﬁcantly associated with
several end-points: in particular age, comorbidities and ongoing (at
the time of analysis) oncological medical therapies can deeply and
negatively inﬂuence the patients’ answers.
4. Discussion
QoL is a wide-ranging concept that embraces a person’s physical
and psychological health, level of independence level, social aspects
and their relationship with the environment. 1 What is more, the
health-related QoL should include psychological, physical and social
aspects. 2
Gastric surgery is a major operation, which can cause a related
potential deterioration in the patient’s QoL. It has amassive impact on
the anatomy and on the physiology of the patient because it changes
the digestive functions and it often affects the patient’s relation with
food.
The implications of gastric surgery for QoL have been evaluated
via the EORTC QLQ-C30 and QLQ-STO22, in particular considering
the following factors: loss of appetite, nausea, diarrhea and anxiety,
discomfort during eating, epigastric pain, postprandial belching and
worrying about low weight. All of these negative elements seem
to be worsened when oncological clearance necessitates a total
gastrectomy. 11–13 The results of the present study are consistent with
the literature, showing worse QoL and health status evaluation for
patients who underwent TG (Table 2, Fig. 1).
In particular, in order to compare in terms of QoL the outcome
of different surgical reconstructions, we analyzed the subgroup of
patients who underwent SG with either Roux-en-Y or Billroth II
reconstruction. Billroth’s procedures (I and II) are more often
performed in Eastern countries for the simplicity of the surgical
techniques compared to Roux-en-Y. In theory, they are prone to
causing duodenum–gastric reﬂux 14 which producesmany symptoms
that negatively affect QoL. 15 In contrast, Roux-en-Y reconstruction –
despite being a more risky and more complex procedure as two
anastomoses must be performed – less frequently causes reﬂux
symptoms. For this reason this surgical reconstruction is more often
used, in particular in case of obese patientsmore prone to duodenum–
gastric reﬂux. 16
As the choice of technique is often driven by the surgeon’s
preferences, only a few studies on QoL after gastric surgery have
been published so far. One of the most important and recent reports
is Liang Zong and Ping Chen’s meta-analysis of 15 trials involving
2169 patients. They compared Billroth I, Billroth II and Roux-en-Y,
concluding that Roux-en-Y reconstruction is more effective in
preventing duodenum–gastric and esophagus–gastric reﬂux, with
a related better QoL. 17 Additionally, Avery et al. administered the
EORTCQLQ-C30 andQLQ-STO22 questionnaires to 58 patients treated
via the Roux-en-Y reconstruction: they concluded that gastrectomy
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(a) (b)
Fig. 1. Patients who underwent total gastrectomy had (a) worse QoL and (b) worse health status evaluation than patients who underwent subtotal gastrectomy, as can be seen
especially by the numbers of answers with a negative judgment (scores 1–4).
(a) (b)
Fig. 2. After SG, patientswhounderwent Billroth II reconstruction had (a)worseQoL and (b)worse health status evaluation than patientswhounderwent Roux-en-Y reconstruction,
as can be seen especially by the numbers of answers with a negative judgment (scores 1–4).
(total and subtotal) for cancer has a temporary negative impact on
most of the aspects of QoL; however they noticed that there is a
positive trend in the years after surgery. 18 Kaptein and colleagues,
analyzing 26 studies, conclude that psychological help can be
useful in improving QoL after gastric surgery. 19 Moreover, in a
prospective randomized study D’Amato et al. histologically analyzed
the lesions (mainly related to duodenum–gastric reﬂux) localized
in the gastric stump after SG: they concluded that histological
lesions are less frequent in Roux-en-Y reconstruction than in the
Billroth I and BII reconstructions. 20 Our data are consistent with the
literature, showing that Roux-en-Y produces better results (Table 3,
Fig. 2), but we additionally showed that it seems to produce more
dumping syndrome-related symptoms.
Even though this study represent a well-conducted analysis on a
challenging topic we must admit some limitations. Firstly, the main
drawback is in the retrospective nature of this study and the related
low level of evidence (despite the large sample). What is more, since
the primary end-point measured, i.e. the QoL, is by deﬁnition difﬁcult
to assess objectively, it is quite hard to conduct standardized studies
on this topic.We attempted to overcome this initial difﬁculty by using
internationally well validated questionnaires. Finally, ab initio there
were some potential confounding factors related to the time interval
between the surgical operation and the interview. These factors have
been considered in the analysis but their effect on our conclusions
cannot be assessed precisely.
In conclusion, taking the declared limitations into account, our
data showed that QoL after gastric surgery for cancer is affected by
tumor- and treatment-related factors. In order to improve patients’
QoL after gastrectomy for cancer, subtotal resection with Roux-
en-Y reconstruction should be preferred whenever oncologically
acceptable. More studies on this topic are needed in the future,
hopefully of prospective multicentered design, in order to better
understand the real implications of gastric surgery for the wellbeing
of patients.
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